Targeting gut flora to prevent progression of hepatocellular carcinoma

Journal of Hepatology

Volumn 58, Issue 2, 2013, Pages 385-387

  Darnaud, Marion ^a,b   Faivre, Jamila ^a,b   Moniaux, Nicolas ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Dysbiosis; Innate immunity; Liver cancer; Microbiome

Indexed keywords

ANTIBIOTIC AGENT; EPIREGULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4;

ANTIBIOTIC THERAPY; APOPTOSIS; BACTERIAL TRANSLOCATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LIVER DISEASE; EXTRACELLULAR MATRIX; FECES; FIBROGENESIS; HEPATITIS; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; METABOLIC SYNDROME X; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; TUMOR PROMOTION;

EID: 84872398737     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.08.019     Document Type: Note

References (10)

1. S. Maeda, H. Kamata, J.L. Luo, H. Leffert, and M. Karin IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis Cell 121 2005 977 990
2. J.P. Nolan The role of intestinal endotoxin in liver injury: a long and evolving history Hepatology 52 2010 1829 1835
3. L.X. Yu, H.X. Yan, Q. Liu, W. Yang, H.P. Wu, and W. Dong Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents Hepatology 52 2010 1322 1333
4. D.H. Dapito, A. Mencin, G.Y. Gwak, J.P. Pradere, M.K. Jang, and I. Mederacke Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 Cancer Cell 21 2012 504 516
5. D.E. Fouts, M. Torralba, K.E. Nelson, D.A. Brenner, and B. Schnabl Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease J Hepatol 56 2012 1283 1292
6. J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, and T. Strowig Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
7. A.W. Yan, D.E. Fouts, J. Brandl, P. Starkel, M. Torralba, and E. Schott Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 2011 96 105
8. J.G. Fox, Y. Feng, E.J. Theve, A.R. Raczynski, J.L. Fiala, and A.L. Doernte Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens Gut 59 2010 88 97
9. H.L. Zhang, L.X. Yu, W. Yang, L. Tang, Y. Lin, and H. Wu Profound impact of gut homeostasis on chemically induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats J Hepatol 57 2012 803 812
10. A. Vrieze, N.E. van, F. Holleman, J. Salojarvi, R.S. Kootte, and J.F. Bartelsman Transfer of intestinal microbiota from lean donors increases insulin sensitivity in subjects with metabolic syndrome Gastroenterology 143 2012 913 916